Product logins

Find logins to all Clarivate products below.


Anna Vlasova

Associate Director for Discovery and Translational Science Consulting

Anna is a seasoned bioinformatics and translational research leader with more than 15 years of experience at the intersection of data science, biology, and data-driven biomedical research. She supports pharmaceutical and biotechnology clients in defining research strategies, solving complex data challenges, and generating insights that advance drug discovery and translational research.

In her current role, Anna leads client engagements from opportunity assessment and project scoping through delivery and stakeholder communication. She works closely with scientific and business stakeholders to understand research objectives, develop analytical strategies, build multidisciplinary teams, and ensure successful project execution. Her expertise spans multi-OMICs and single cell analytics, biomarker discovery, data engineering, and AI-enabled solutions, helping organizations unlock greater value from biological and clinical data. A central focus of her work is translating complex scientific questions into practical, data-driven strategies that support innovation and informed decision-making.

Anna holds an MSc in Applied Mathematics and Computer Genetics and has a particular interest in the molecular mechanisms underlying disease, specifically transcriptional regulation and cancer biology.

Related resources

Multi-product portfolios: addressing complexity through smarter value communication Multi-product portfolios: addressing complexity through smarter value communication
Blog October 9, 2026
Multi-product portfolios: addressing complexity through smarter value communication
Biopharma Commercialization HMO HTA Launch Managed care MCO Payer PBM Pharma pricing
Understanding the impact of drug shortages across markets for API manufacturers Understanding the impact of drug shortages across markets for API manufacturers
Blog October 9, 2026
Understanding the impact of drug shortages across markets for API manufacturers
Biopharma Manufacturing Real-World Data Supply chain
From promise to payment: pricing and reimbursement for combination oncology regimens From promise to payment: pricing and reimbursement for combination oncology regimens
Blog October 9, 2026
From promise to payment: pricing and reimbursement for combination oncology regimens
Biopharma Biotech Bispecific antibodies BsAb Clinical trials Commercialization EMA EMEA Europe HTA Launch Market Access Oncology Payer Pharma Policy pricing
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research